GlaxoSmithKline wants to sell more than a third of the space at its R&D campus in Stevenage, UK, to a new bioscience cluster that it says could become one of the largest in Europe.

It will allow swift transport links to GSK's main R&D campus in Stevenage – where the company is also developing a new bioscience cluster – and will also be close to its artificial ...

“Our HQ is in Angel, London, and our labs are at the Stevenage Bioscience Catalyst, We chose the SBC due to its incredible facilities, flexibility to grow with the company, and close proximity to ...

Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...

Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...

Correspondence to Dr Paul P Tak, GlaxoSmithKline Research and Development, Stevenage SG1 2NY, UK; Paul-peter.x.tak{at}gsk.com Objectives Interleukin-6 (IL-6) is implicated in rheumatoid arthritis (RA) ...

GSK is funding public health organizations working to address US adult immunization gaps and increase community vaccine education, outreach and access These grants are part of GSK’s COiMMUNITY ...

GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of oral antibiotics for the condition in nearly 30 years. Blujepa, also ...

Shortly after President Donald Trump won his second presidential election in the U.S. last fall, British drugmaker GSK came to federal prosecutors in New York, bearing intel from employees ...

In spring 2021, my family sold a big lump of GSK shares. Four years later, we have no regrets. Indeed, with the GSK share price stumbling, we may buy soon. When investing, your capital is at risk.